Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 861177 NEW YORK, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$66,513,866
+$24,010,781 QoQ
Shares Held
210,427
-1.2% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. LGND ranks #13 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,513,866 210,427
2026-03-31 $42,503,085 212,888
2025-12-31 $68,742,822 363,584
2025-09-30 $66,711,097 376,601
2025-06-30 $44,538,569 391,789
2025-03-31 $5,817,078 55,327
2024-12-31 $5,400,465 50,401
2024-09-30 $3,987,382 39,838
2024-06-30 $3,864,918 45,869
2024-03-31 $1,150,520 15,739
2023-12-31 $1,124,077 15,739
2023-09-30 $943,079 15,739
2023-06-30 $1,344,736 18,651
2023-03-31 $1,371,964 18,651
2022-12-31 $1,177,081 17,621
2022-09-30 $1,517,341 17,621
2022-06-30 $1,572,142 17,621
2022-03-31 $2,446,655 21,750
2021-12-31 $3,165,345 20,493
2021-09-30 $2,989,942 21,461
2021-06-30 $2,886,177 22,000
2021-03-31 $2,741,353 17,982
2020-12-31 $1,733,609 17,432
2020-09-30 $8,394,354 88,065
2020-06-30 $2,097,632 18,754
2020-03-31 $1,363,206 18,746